DCN Dx Acquires Point-Of-Care Diagnostics Development Company PortaScience
DCN Dx, an international provider of point-of-care diagnostics development, has announced completing its acquisition of PortaScience, Inc.
Read MorePosted by Chris Wolski | Jun 18, 2021 | Point-of-Care |
DCN Dx, an international provider of point-of-care diagnostics development, has announced completing its acquisition of PortaScience, Inc.
Read MorePosted by Chris Wolski | Jun 18, 2021 | Covid 19, Molecular Diagnostics, POC Rapid Assays |
Roche has announced that the U.S. FDA has granted EUA for the cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System.
Read MorePosted by Melanie Hamilton-Basich | Jun 15, 2021 | Covid 19 |
Researchers discovered commercially available PCR tests can withstand the freeze-drying process, making them shelf-stable for up to 30 days and 122 degrees Fahrenheit, without sacrificing sensitivity and accuracy.
Read MorePosted by Chris Wolski | Jun 15, 2021 | Covid 19, Emerging & Zoonotic Diseases, POC Rapid Assays |
Pandemic preparedness requires long-term investments in disease surveillance, diagnostics, therapeutics, and vaccine research.
Read MorePosted by Chris Wolski | May 27, 2021 | Covid 19 |
The PCR portion of an RT-PCR test takes about an hour. Researchers have developed a chip that can perform PCR in only about 8 minutes.
Read More